Atrial Fibrillation Registry in Jordan

Atrial Fibrillation Clinical Trial

— JoAFR  

Official title:

Atrial Fibrillation Registry in Jordan

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02680483
• Other study ID #: JoAFR-JCCG
• Status: Terminated
• Start date: August 2016
• Est. completion date: March 2018

Study information

• Verified date: May 2023
• Source: Jordan Collaborating Cardiology Group
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Prospective registry of all new comers with Atrial fibrillation

Description:

12 tertiary care centers will enroll all AF comers. Details of baseline clinical, EKG, echo, and lab data will be documented for all patients. Management is according to the physicians discretion. Patients will be followed up for 1 year for clinical endpoints including cardiovascular death, stroke, heart failure, systemic embolization and bleeding.. Anticoagulants and other cardiovascular medications will also be documented.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 2000
• Est. completion date: March 2018
• Est. primary completion date: August 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• Admission with atrial fibrillation

• developing atrial fibrillation during hospitalization for mon AF reason.

• age 18 or more years.

• patients welling to participate in the registry.

Exclusion Criteria:

• age less than 18 years.

• patients not welling to participate.

Related Conditions & MeSH terms

• Atrial Fibrillation

Locations

Country	Name	City	State
Jordan	Istishari hospital	Amman

Sponsors (1)

Lead Sponsor	Collaborator
Jordan Collaborating Cardiology Group

Country where clinical trial is conducted

Jordan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Incidence of stroke and systemic embolization and cardiovascular death	all ischemic and hemorrhagic strokes and embolization to any arterial bed during follow up period	1 year
Secondary	Number of readmission for atrial fibrillation	readmission for atrial fibrillation related problem other than primary such as palpitations, hypotension, syncope, or near syncope.	1 year
Secondary	Number of readmission for other cardiovascular events	Atrial Fibrillation in Jordan: risk factors, presentations, in hospital management, long term management, clinical events in hospital and at one year	1 year